[The interpretation of laboratory parameters in evaluating the immune status of man]

Laboratornoe Delo
|January 1, 1991
PubMed

Insights

Assessing patient immunity involves evaluating immunocyte activation, proliferation, and differentiation. Novel immunobiotechnology simplifies the interpretation of human immune system studies, focusing on lymphocytes and other key immune cells.

Area of Science:

  • Immunology
  • Biotechnology

Context:

  • Assessing patient immunity is crucial for disease management.
  • Current methods for evaluating immune status can be complex.

Purpose:

  • To identify key physiologic parameters for assessing patient immunity.
  • To introduce novel immunobiotechnology for simplified immune status evaluation.

Summary:

  • Three physiologic parameters—immunocyte activation, proliferation, and differentiation—are key for assessing immunity.
  • Novel immunobiotechnology enables direct examination of these parameters.
  • The approach simplifies interpretation of human immune system studies, including lymphocytes, monocytes, macrophages, and granulocytes.

Impact:

  • Simplifies the interpretation of immune status assessments.
  • Highlights the role of various immune cells (lymphocytes, monocytes, macrophages, granulocytes) in disease pathogenesis.
  • Provides a foundation for improved diagnostics and understanding of immune-related diseases.